91 related articles for article (PubMed ID: 16898005)
21. Phase II study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma.
Nakazawa M; Ohnishi T; Ohmae M; Chisoku H; Yui S; Iwai S; Sumi T; Fukuda Y; Kishino M; Yura Y
Int J Clin Pharmacol Res; 2005; 25(3):115-22. PubMed ID: 16366419
[TBL] [Abstract][Full Text] [Related]
22. [Two cases of CPT-11 and CDDP chemotherapy for advanced pancreatic cancer].
Takagi K; Kawamoto K; Itoh T
Gan To Kagaku Ryoho; 2012 May; 39(5):847-9. PubMed ID: 22584347
[TBL] [Abstract][Full Text] [Related]
23. [A case of long-term survival of gastric cancer with peritoneal metastasis effectively treated by TS-1 and paclitaxel (PTX) combination therapy].
Tanaka K; Kanamaru T; Yamamoto M
Gan To Kagaku Ryoho; 2006 Jul; 33(7):993-6. PubMed ID: 16835495
[TBL] [Abstract][Full Text] [Related]
24. [Progress in chemotherapy for colorectal cancer].
Sasaki T; Maeda Y
Gan To Kagaku Ryoho; 2000 Dec; 27(14):2185-92. PubMed ID: 11142161
[TBL] [Abstract][Full Text] [Related]
25. [Second-line chemotherapy in gastric cancer following S-1 with CPT-11 chemotherapy performed as clinical trial].
Inokuchi M; Yamashita T; Yamada H; Kojima K; Sekita Y; Kawano T; Sugihara K
Gan To Kagaku Ryoho; 2007 Jun; 34(6):875-9. PubMed ID: 17565249
[TBL] [Abstract][Full Text] [Related]
26. Feasibility study of triplet combination chemotherapy of paclitaxel, cisplatin and S-1 for advanced gastric cancer.
Fujitani K; Hasegawa H; Hirao M; Kurokawa Y; Tsujinaka T
Anticancer Res; 2011 Sep; 31(9):3085-91. PubMed ID: 21868564
[TBL] [Abstract][Full Text] [Related]
27. A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer.
Jiang H; Qian J; Zhao P; Zhang X; Zheng Y; Mao C; Zheng Y; Chen L; Wang Y; Mou H; Fang W; Teng L; Xu N
Cancer Chemother Pharmacol; 2015 Jul; 76(1):197-203. PubMed ID: 26013324
[TBL] [Abstract][Full Text] [Related]
28. [A Case of advanced gastric cancer successfully treated with TS-1/low-dose CDDP as neoadjuvant chemotherapy].
Yamada K; Sugiyama Y; Seino K; Kobori H; Ebina T; Shibata S; Kawasaki H; Sasaki M; Tanaka M
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1447-51. PubMed ID: 16227746
[TBL] [Abstract][Full Text] [Related]
29. Mediastinal signet-ring cell carcinoma of unknown primary: long-term survival by treatment with S-1, a novel derivative of 5-fluorouracil.
Kusakari C; Soda H; Nakamura Y; Yamaguchi H; Kitazaki T; Nakano H; Matsubara Y; Hayashi T; Nagasaki T; Nagayasu T; Kohno S
Lung Cancer; 2007 Apr; 56(1):139-41. PubMed ID: 17208329
[No Abstract] [Full Text] [Related]
30. Second-line therapy in pancreatic cancer.
Skoura E; Syrigos KN; Saif MW
JOP; 2013 Mar; 14(2):133-4. PubMed ID: 23474554
[TBL] [Abstract][Full Text] [Related]
31. [Combination chemotherapy with S-1 and cisplatin for non-small cell lung cancer].
Wataya H; Ichinose Y
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():194-6. PubMed ID: 16898001
[TBL] [Abstract][Full Text] [Related]
32. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study.
Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A
Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231
[TBL] [Abstract][Full Text] [Related]
33. A phase I study of bi-weekly combination therapy with S-1 and docetaxel for advanced or recurrent gastric cancer.
Rino Y; Takanashi Y; Yukawa N; Saeki H; Wada H; Kanari M; Yamada R; Satoh T; Yamamoto N; Imada T
Anticancer Res; 2006; 26(2B):1455-62. PubMed ID: 16619558
[TBL] [Abstract][Full Text] [Related]
34. [Combination therapy of continuous venous infusion (CVI) of 5-FU and low dose consecutive cisplatin (CDDP), and the new oral anti-cancer drug S-1 for advanced gastro-intestinal cancer].
Shirasaka T; Aiba K; Araki H; Suzuki M; Terashima M; Mikami Y
Gan To Kagaku Ryoho; 1999 Mar; 26(4):456-66. PubMed ID: 10097742
[TBL] [Abstract][Full Text] [Related]
35. [Clinical experience of chemotherapy with S-1/CDDP for highly-advanced gastric cancer].
Uchima Y; Kosaka K; Kimura K; Okita Y; Sim JK; Aomatsu N; Hirata K; Lee WH; Lee T; Nishii T; Tei S; Takeuchi K
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1287-90. PubMed ID: 20647711
[TBL] [Abstract][Full Text] [Related]
36. A phase I study of triplet combination chemotherapy of paclitaxel, cisplatin and S-1 in patients with advanced gastric cancer.
Kimura Y; Yano H; Imamura H; Fujitani K; Imano M; Tokunaga Y; Matsuoka M; Kurokawa Y; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H
Jpn J Clin Oncol; 2013 Feb; 43(2):125-31. PubMed ID: 23225911
[TBL] [Abstract][Full Text] [Related]
37. [Radiotherapy combined with S-1 and cisplatin for locally advanced and metastatic esophageal cancer].
Iwase H
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():224-9. PubMed ID: 16898007
[TBL] [Abstract][Full Text] [Related]
38. [A pilot study of low-dose TS-1 and cisplatin combination chemotherapy for advanced gastric cancer].
Kamata T; Hayashi Y; Minatoya G; Michiwa Y; Onishi I; Takeda T; Koyasaki N; Kanno M
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1419-22. PubMed ID: 11681250
[TBL] [Abstract][Full Text] [Related]
39. [Adjuvant regional chemotherapy in resected advanced pancreas carcinoma].
Gansauge F; Link KH; Rilinger N; Kunz R; Beger HG
Chirurg; 1996 Apr; 67(4):362-5. PubMed ID: 8646922
[TBL] [Abstract][Full Text] [Related]
40. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH
J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]